FEB 24, 2016 2:00 PM PST

Why we should clinically classify genotypes, not variants

Speaker
  • Senior Director, Scientific Engagement & Public Outreach, New York Genome Center
    Biography
      Nathan Pearson is a Senior Director of Scientific Engagement & Public Outreach at NY Genome Center, where he and his colleagues build simple, engaging tools that compare one whole human genome to the next, in order to cast new light on human health and history. Fascinated by human genetic diversity since working as a young student in the laboratory of Luca Cavalli-Sforza (Stanford University), he traveled with Spencer Wells (now head of the Genographic Project) to collect DNA from people living throughout Eurasia, to reveal traces of ancient migrations recorded in their genomes. In doctoral work at the University of Chicago, he studied patterns of sequence variation on the great ape sex chromosomes, spotlighting how mutation, recombination, and natural selection have jointly made the X and Y ever more different from each other. Later, in post-doctoral work at the University of Michigan, he first delved into the emerging world of high-throughput sequencing, grasping its power to address important open questions in biology. Today, working with a talented team of scientists and programmers, he helps researchers and consumers sift through the billions of letters in each human genome, and understand which important spellings make each person unique.

    Abstract

    A century and a half after we first probed heritability, we risk forgetting one of Mendel's own basic findings, in rushing to broaden clinical genomics to lifelong care for all. Embracing that key insight now -- as we long have in tracking the chemistry of health -- can help gird our health infrastructure for the long haul.

    Learning objectives

    • Conventionally, we clinically classify and report genomic variants.
    • That habit -- rooted in early clinical genomics (reading few genes, in few people, mostly sick) -- presumes that disease cases trace mainly to strongly acting single variants...so sweeps widespread real impenetrance, for major diseases, under a vast rug.
    • Classifying and reporting genotypes would more neatly and realistically track non-additive genomic interactions mined from emerging data, girding healthcare for broad longterm genomic utility.
    •  The history of toxicology (and of early genetics too!) starkly highlights this lesson, and suggests simple but urgent steps that stakeholders (genomicists, informaticians, caregivers, and patients) should take now.


     


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    Loading Comments...
    Show Resources